These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7693769)

  • 1. The role of alpha 1-blockade in benign prostatic hyperplasia.
    Brawer MK
    J Clin Pharmacol; 1993 Sep; 33(9):891-5. PubMed ID: 7693769
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I
    Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
    Caine M
    Urology; 1988 Dec; 32(6 Suppl):16-20. PubMed ID: 2462300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy for benign prostatic hyperplasia.
    Lepor H
    Urology; 1993 Nov; 42(5):483-501. PubMed ID: 7694413
    [No Abstract]   [Full Text] [Related]  

  • 6. Terazosin for BPH.
    Jerant AF
    J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
    [No Abstract]   [Full Text] [Related]  

  • 7. Terazosin now indicated for benign prostatic hyperplasia.
    Am J Hosp Pharm; 1994 Jan; 51(1):25. PubMed ID: 7510930
    [No Abstract]   [Full Text] [Related]  

  • 8. Terazosin for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
    [No Abstract]   [Full Text] [Related]  

  • 9. FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.
    Rich KT; Safranek S
    Am Fam Physician; 2008 Mar; 77(5):665-6. PubMed ID: 18350766
    [No Abstract]   [Full Text] [Related]  

  • 10. Terazosin, finasteride, or both in benign prostatic hyperplasia.
    Kuchel GA; DuBeau CE; Resnick NM
    N Engl J Med; 1997 Jan; 336(4):293-4; author reply 294. PubMed ID: 9005317
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of benign prostatic hyperplasia.
    Walsh PC
    N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostatic adenoma: new drugs, new surgical techniques].
    Heinzl S
    Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the best medical treatment for benign prostate hyperplasia?
    Evans MF; Frank J
    Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
    [No Abstract]   [Full Text] [Related]  

  • 14. The medication minute: terazosin.
    Bartek JK; McNamee M
    Urol Nurs; 1995 Jun; 15(2):67-8. PubMed ID: 7541161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
    Bouffioux CR; Penders L
    Eur Urol; 1984; 10(5):306-10. PubMed ID: 6083868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.
    Geller J; Kirchenbaum A; Lepor H; Levine AC
    J Clin Endocrinol Metab; 1995 Mar; 80(3):745-7. PubMed ID: 7533770
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
    Caine M
    Urol Clin North Am; 1990 Aug; 17(3):641-9. PubMed ID: 1695784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
    Chapple CR
    Br J Urol; 1998 Mar; 81 Suppl 1():34-47; discussion 64-6. PubMed ID: 9589016
    [No Abstract]   [Full Text] [Related]  

  • 20. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.